Abstract
Gemcitabine in combination with pegylated liposomal doxorubicin has been recognized as an effective treatment in patients with refractory solid tumors. To our knowledge, this is the first case of relapsed Hodgkin lymphoma with breast involvement successfully treated with this association.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Antibiotics, Antineoplastic / administration & dosage*
-
Antimetabolites, Antineoplastic / administration & dosage*
-
Breast Neoplasms, Male / diagnostic imaging
-
Breast Neoplasms, Male / drug therapy*
-
Breast Neoplasms, Male / secondary
-
Deoxycytidine / administration & dosage
-
Deoxycytidine / analogs & derivatives*
-
Doxorubicin / administration & dosage*
-
Gemcitabine
-
Hodgkin Disease / complications
-
Hodgkin Disease / diagnostic imaging
-
Hodgkin Disease / drug therapy*
-
Humans
-
Male
-
Radiography
-
Recurrence
Substances
-
Antibiotics, Antineoplastic
-
Antimetabolites, Antineoplastic
-
Deoxycytidine
-
Doxorubicin
-
Gemcitabine